Immunotherapy: Open Access

Immunotherapy: Open Access
Open Access

ISSN: 2471-9552

Volume 10, Issue 3 (2024)

Opinion Article

Pages: 1 - 2

Beyond Conventional Approaches: The Role of Immunotherapy in Enhancing Treatment Outcomes

Yang Cho Kim*

DOI: 10.35248/2471-9552.24.10.262

Share this article

Opinion Article

Pages: 1 - 2

A Comparative Analysis of Sublingual Immunotherapy and Conventional Treatments

Hamta Ishiwara*

DOI: 10.35248/2471-9552.24.10.261

Share this article

Opinion

Pages: 1 - 2

Potential Impact of Immunotherapy on Long-term Management of Type 1 Diabetes

Mark Ciemenn*

DOI: 10.35248/2471-9552.24.10.263

Share this article

Perspective

Pages: 1 - 2

Biomarkers and their Impact on Cancer Treatment in the Field of Immunotherapy

Medina Olmedo*

DOI: 10.35248/2471-9552.24.10.260

Share this article

Case Report

Pages: 1 - 4

Use of an Anti-CD6 Antibody (Itolizumab) for the Treatment of COVID-19 Patients with Cytokine Release Syndrome Report of Three Cases

Lazaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle, Carlos Herrera, Carlos Figueredo, Jorge Alain Caballero, Naivy Sanchez, Jorge Berrio, Geidy Lorenzo, Meylan Cepeda, Mayra Ramos, Danay Saavedra, Ana Laura Ane-Kouri, Zaima Mazorra*, Kalet Leon, Tania Crombet and Armando Caballero

DOI: 10.35248/2471-9552.24.10.257

Share this article

Research Article

Pages: 1 - 11

Efficacy and Safety of Transarterial Chemoembolization Combined with First-Line Tyrosine Kinase Inhibitors and Programmed Death-1 Inhibitors for Progressed Hepatocellular Carcinoma

Wei-Zhu Yang*, Long-Wang Lin, Yu-Xia Nian, Rong Chen, Kun Ke, Jun-Qing Lin and Ning Huang*

DOI: 10.35248/2471-9552.24.10.259

Share this article

Commentary

Pages: 1 - 2

Melanoma Immunotherapy: Its Recent Advances in Patients and Revolution

Kerry Hannah*

DOI: 10.35248/2471-9552.24.10.258

Share this article
Top